Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist

Elife. 2020 Aug 28:9:e57670. doi: 10.7554/eLife.57670.

Abstract

How the brain dynamics change during anesthetic-induced altered states of consciousness is not completely understood. The α2-adrenergic agonists are unique. They generate unconsciousness selectively through α2-adrenergic receptors and related circuits. We studied intracortical neuronal dynamics during transitions of loss of consciousness (LOC) with the α2-adrenergic agonist dexmedetomidine and return of consciousness (ROC) in a functionally interconnecting somatosensory and ventral premotor network in non-human primates. LOC, ROC and full task performance recovery were all associated with distinct neural changes. The early recovery demonstrated characteristic intermediate dynamics distinguished by sustained high spindle activities. Awakening by the α2-adrenergic antagonist completely eliminated this intermediate state and instantaneously restored awake dynamics and the top task performance while the anesthetic was still being infused. The results suggest that instantaneous functional recovery is possible following anesthetic-induced unconsciousness and the intermediate recovery state is not a necessary path for the brain recovery.

Keywords: awakening; general anesthesia; medicine; neuroscience; rhesus macaque; unconsciousness; α2-adrenergic agonist.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / administration & dosage*
  • Adrenergic alpha-Antagonists / administration & dosage
  • Animals
  • Brain / drug effects*
  • Brain / physiopathology
  • Consciousness / drug effects*
  • Dexmedetomidine / administration & dosage*
  • Electroencephalography
  • Humans
  • Hypnotics and Sedatives
  • Imidazoles / administration & dosage
  • Macaca
  • Male
  • Unconsciousness / chemically induced*
  • Unconsciousness / physiopathology
  • Wakefulness / drug effects

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Hypnotics and Sedatives
  • Imidazoles
  • atipamezole
  • Dexmedetomidine

Associated data

  • Dryad/10.5061/dryad.98sf7m0ft